Syneos Health

How can trusted voices cut through the noise in healthcare?   At #FPW25, Doctor Mike will share his perspective in a Spotlight Session moderated by our own Marcie Doser and Andrea Dagger.

Nearly 2,000 sites. 16,300+ data points. One prestigious honor. 🦅 The SCRS Eagle Award recognizes pharmaceutical companies & CRO teams who set the standard for site partnerships and clinical research excellence. Congratulations to the 2025 Eagle Award Finalists! Sponsors: AstraZeneca, Eli Lilly and Company, MSD, Novo Nordisk, Pfizer, Sanofi CROs: Fortrea, IQVIA, Medpace, Parexel, Thermo Fisher Scientific, Syneos Health

For more than 30 years, our specialized Early Phase team has been dedicated to meeting the unique challenges of this phase of research. With more than 250 Phase I studies conducted in the past five years, we deliver innovative, customized solutions that generate high-quality, actionable data to inform your strategic decision-making. Explore new possibilities in early phase research with Syneos Health: https://lnkd.in/dBwiGyVJ #SyneosHealth #EarlyPhase #ClinicalTrials

Syneos Health is heading to Meeting on the Mesa 2025 — the industry’s leading Cell & Gene therapy event. We’ll be demonstrating our innovation and expertise across the full development cycle, from advanced clinical development and study design to strategic and commercial planning and operational execution. Join us in Phoenix to discuss how we can accelerate your next breakthrough. Book a meeting with our team: https://lnkd.in/eAm4CJeN #CellAndGeneTherapy #ClinicalResearch #PharmaInnovation #RareDisease #Biopharma #MeetingOnTheMesa

Syneos Health is proud to announce that we have been named a finalist for the 2025 Society for Clinical Research Sites (SCRS) Eagle Award! This recognition reflects our commitment to strong site partnerships and advancing clinical research through collaboration, innovation and operational excellence. We are looking forward to the winners being announced at the SCRS Site Solutions Summit on September 30th. We’ll be on the ground – let’s connect: https://lnkd.in/eSB5vmfC #SyneosHealth #SCRSEagleAward #ClinicalResearch

As pharma embraces the promise of AI, one truth is clear: scaling AI responsibly requires more than algorithms — it requires people. In our new Insights Hub blog, Adam Kennedy, VP, Executive Search at TSP, and Shigeto M., VP, Digital Solutions at Syneos Health, discuss how to: -Embed AI ethics and governance to prevent bias and safeguard compliance -Structure teams with leaders, explainers and sustainers to ensure AI adoption is scalable and impactful -Move AI out of silos and into the heart of R&D, commercial and supply chain operations The future of AI in pharma isn’t just about innovation — it’s about sustainable, ethical integration. Explore their perspectives: https://lnkd.in/ecZzxrWi #AIinPharma #LifeSciences #EthicalAI #Innovation #SyneosHealth

Syneos Health is gearing up for the SRCS Site Solutions Summit where our leaders will share insights on building stronger site partnerships and advancing patient-focused research. -Ashley C Moultrie, CCRP will explore the power of effective communication -Jade Tuttle, LMSW will lead a discussion amplifying the patient voice -Rachel Cox will highlight strategies for community visibility and engagement Book a meeting today: https://lnkd.in/eSB5vmfC #SyneosHealth #SCRSSiteSolutionsSummit #ClinicalTrials

Investor enthusiasm for CGT companies can be high, but it can also be fragile. Even companies with strong clinical data may struggle to secure follow-on funding. Vote below and check back next week for the results — and the strategic lessons behind them.

Syneos Health is sharing thought leadership at KoNECT International Conference 2025 — advancing conversations on market entry, trial design, value and patient engagement. Catch our experts on stage: -In Pyo Hong — Navigating US Market Entry | Sept 22, 4:25 PM KST -JUNG OK JANG — Risk Navigation: Operational Insights for Superior Study Risk Management | Sept 23, 4:10 PM KST -Ronan Bouër — Optimizing Clinical Development Strategies to Maximize Drug Value | Sept 23, 1:30 PM KST -So-Ra Lee — Expanding Korea’s Clinical Trial Landscape | Sept 23, 10:30 AM KST and Clinical Design Strategies to Enhance Drug Value from Early Development Stages (Chair) | Sept 23, 1:30 PM KST Join us as we help shape the future of clinical research: #SyneosHealth #KoNECT2025 #ClinicalTrials

We’re bringing the smartest launch strategies to the fiercest week in pharma. At Fierce Pharma Week, join Naveen Murthy and Hruta Shah for their session: Maximizing Launch Impact: Invest Early, Spend Smart. Discover how experienced executives: -Approach funding decisions with confidence -Use data to guide successful investments -Avoid common pitfalls in launch timing and functional allocation Don’t miss this opportunity to gain actionable insights that can help you stand out in a competitive market and maximize your product’s launch success. Make it a must-attend on your agenda — we’ll see you in Philly! #SyneosHealth #FiercePharma2025 #LaunchStrategy #Biopharma